Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs

Curr Pharm Biotechnol. 2016;17(3):248-55. doi: 10.2174/1389201017666151030104944.

Abstract

Among the difficulties encountered in the treatment of cancer are the physico-chemical properties of the chemotherapeutic agents; in particular low water solubility and low stability, resulting in poor efficacy. Due to their capability to form molecular inclusions with apolar molecules (or part of them) cyclodextrins constitute a powerful tool to prepare more efficient chemotherapeutic delivery systems such as nanoparticles. This review focuses on polymeric nanoparticles for cancer therapy prepared from either cyclodextrin molecules, or polymer and cyclodextrins.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / therapeutic use
  • Cyclodextrins / chemistry*
  • Drug Carriers / chemistry
  • Humans
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy*
  • Polymers / chemistry

Substances

  • Antineoplastic Agents
  • Cyclodextrins
  • Drug Carriers
  • Polymers